BACKGROUND: Roux-en-Y gastric bypass (RYGBP) has been found to be the most efficient way to lose weight and maintain the weight loss in morbid obesity. However, with the formation of a new stomach and the modification of intestinal anatomy, there are significant changes on physiological properties of these organs that lead to nutrient deficiency, including calcium. The objectives of this study were to evaluate calcium intake, bone metabolism, and prevalence of metabolic bone disease in women subjected to RYGBP after 8 years. METHODS: Food frequency questionnaire and 3-day dietary recall, laboratory tests of bone metabolism and bone mineral density were accessed. RESULTS: Calcium intake was below the recommendation in all women. Serum PTH and alkaline phosphatase were elevated, whereas vitamin D and urinary calcium were significantly lower. Also, a higher prevalence of metabolic bone disease than the one expected for the normal population at the same age was noted. CONCLUSION: These data suggest that metabolic bone disease could be a complication of this type of surgery.
BACKGROUND: Roux-en-Y gastric bypass (RYGBP) has been found to be the most efficient way to lose weight and maintain the weight loss in morbid obesity. However, with the formation of a new stomach and the modification of intestinal anatomy, there are significant changes on physiological properties of these organs that lead to nutrient deficiency, including calcium. The objectives of this study were to evaluate calcium intake, bone metabolism, and prevalence of metabolic bone disease in women subjected to RYGBP after 8 years. METHODS: Food frequency questionnaire and 3-day dietary recall, laboratory tests of bone metabolism and bone mineral density were accessed. RESULTS:Calcium intake was below the recommendation in all women. Serum PTH and alkaline phosphatase were elevated, whereas vitamin D and urinary calcium were significantly lower. Also, a higher prevalence of metabolic bone disease than the one expected for the normal population at the same age was noted. CONCLUSION: These data suggest that metabolic bone disease could be a complication of this type of surgery.
Authors: Penelope S Coates; John D Fernstrom; Madelyn H Fernstrom; Philip R Schauer; Susan L Greenspan Journal: J Clin Endocrinol Metab Date: 2004-03 Impact factor: 5.958
Authors: Luciana J El-Kadre; Paulo Roberto Savassi Rocha; Augusto C de Almeida Tinoco; Renam C Tinoco Journal: Obes Surg Date: 2004-09 Impact factor: 4.129
Authors: Elaine W Yu; Mary L Bouxsein; Adam E Roy; Chantel Baldwin; Abby Cange; Robert M Neer; Lee M Kaplan; Joel S Finkelstein Journal: J Bone Miner Res Date: 2014-03 Impact factor: 6.741
Authors: Gigliane Cosendey Menegati; Louise Crovesy de Oliveira; Anna Lúcia Andrade Santos; Larissa Cohen; Fernanda Mattos; Laura Maria Carvalho Mendonça; João Régis Ivar Carneiro; Maria Lúcia Fleiuss Farias; Eliane Lopes Rosado Journal: Obes Surg Date: 2016-07 Impact factor: 4.129
Authors: Christos Karefylakis; Ingmar Näslund; David Edholm; Magnus Sundbom; F Anders Karlsson; Eva Rask Journal: Obes Surg Date: 2014-03 Impact factor: 4.129
Authors: Nuria Vilarrasa; José Manuel Gómez; Iñaki Elio; Carmen Gómez-Vaquero; Carles Masdevall; Jordi Pujol; Núria Virgili; Rosa Burgos; Raquel Sánchez-Santos; Amador G Ruiz de Gordejuela; Joan Soler Journal: Obes Surg Date: 2009-05-02 Impact factor: 4.129